COVERAGE HUB
$PFE
6 articles in last 30 days
LAST 30 DAYS
6 articles
AVG GRADE
NEUTRAL
score: -0.17
SENTIMENT
BULLISH
TOTAL VIEWS
1
3-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 6 ARTICLES
Top Research Reports for Pfizer, Altria & Newmont Corp.
This research roundup aggregates analyst commentary on 16 major equities spanning pharmaceutical, consumer staples, and precious metals...
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
Pfizer's leadership has provided forward guidance suggesting a return to high-single-digit growth, signaling management confidence in...
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Pfizer (PFE) has attracted elevated retail investor attention on Zacks tracking platforms, signaling potential retail interest or...
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
Bristol Myers Squibb (BMY) is the focal point of this dividend safety assessment, with the company offering a 4.5% yield that...
Why Pfizer Stock Popped Today
Pfizer (PFE) experienced intraday upward momentum, reflecting a constructive reassessment of the pharmaceutical giant's valuation...
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
This comparative analysis between Lexicon Pharmaceuticals (LXRX) and Pfizer (PFE) reflects a fundamental tension in pharmaceutical...
RELATED TICKERS